A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT

NCT04488822 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Tenosynovial Giant Cell Tumor

Interventions

DRUG: Pexidartinib

Sponsor

Daiichi Sankyo Co., Ltd.